Sarah James
Stock Analyst at Cantor Fitzgerald
(2.23)
# 2,441
Out of 4,810 analysts
277
Total ratings
34.58%
Success rate
-3.64%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $328.63 | +11.07% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $24.45 | +18.61% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $5.16 | +190.70% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $120.91 | +46.39% | 20 | Feb 13, 2025 | |
| HUM Humana | Reiterates: Neutral | $290 | $286.78 | +1.12% | 20 | Feb 12, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $335.55 | +20.70% | 19 | Jan 27, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $437.77 | +10.79% | 19 | Jan 24, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $583.59 | +19.95% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $62.28 | +44.51% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $24.73 | +110.27% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $21.81 | -22.05% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $175.50 | +24.79% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $335.50 | +21.01% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $21.07 | +104.08% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $3.70 | +332.43% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $68.92 | -10.04% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $2.25 | +122.22% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.14 | +40.06% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $91.58 | +10.29% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $146.28 | -9.08% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $14.99 | +180.19% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $2.82 | +77.30% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.54 | +10.13% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.43 | +8.08% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $53.08 | -26.53% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $64.28 | +200.25% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.49 | - | 2 | Mar 1, 2017 |
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $328.63
Upside: +11.07%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $24.45
Upside: +18.61%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $5.16
Upside: +190.70%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $120.91
Upside: +46.39%
Humana
Feb 12, 2025
Reiterates: Neutral
Price Target: $290
Current: $286.78
Upside: +1.12%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $335.55
Upside: +20.70%
Elevance Health
Jan 24, 2025
Reiterates: Overweight
Price Target: $485
Current: $437.77
Upside: +10.79%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $583.59
Upside: +19.95%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $62.28
Upside: +44.51%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $24.73
Upside: +110.27%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.81
Upside: -22.05%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $175.50
Upside: +24.79%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $335.50
Upside: +21.01%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $21.07
Upside: +104.08%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $3.70
Upside: +332.43%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $68.92
Upside: -10.04%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $2.25
Upside: +122.22%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.14
Upside: +40.06%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $91.58
Upside: +10.29%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $146.28
Upside: -9.08%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $14.99
Upside: +180.19%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $2.82
Upside: +77.30%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.54
Upside: +10.13%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $19.43
Upside: +8.08%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $53.08
Upside: -26.53%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $64.28
Upside: +200.25%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.49
Upside: -